Bioventus (BVS) SVP granted RSUs, options and exercises prior awards

Rhea-AI Filing Summary

Bioventus Inc. senior vice president and chief compliance officer Katrina J. Church received new equity awards and exercised existing awards. On March 13, 2026 she was granted 24,000 restricted stock units and 27,000 stock options with an exercise price of $8.62 per share, all vesting in four annual installments starting March 15, 2026, subject to continued service.

Church also exercised a total of 6,955 restricted stock units into Class A common stock, with 3,022 shares withheld to cover tax obligations. After these transactions she directly holds 61,732 shares of Class A common stock, plus outstanding RSU and option awards disclosed in the filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

CHURCH KATRINA J

(Last) (First) (Middle)

4721 EMPEROR BOULEVARD, SUITE 100

(Street)

DURHAM NC 27703

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Bioventus Inc. [ BVS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP & Chief Compliance Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/14/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	03/13/2026		M		3,455	A	$0	61,254	D
Class A Common Stock	03/13/2026		F		1,501	D	$8.62	59,753	D
Class A Common Stock	03/13/2026		M		3,500	A	$0	63,253	D
Class A Common Stock	03/13/2026		F		1,521	D	$8.62	61,732	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	03/14/2025		A		14,000		(2)	(2)	Class A Common Stock	14,000	$0	14,000	D
Stock Option (Right to Buy)	$9.61	03/14/2025		A		16,000		(2)	03/14/2035	Class A Common Stock	16,000	$0	16,000	D
Restricted Stock Units	(1)	03/13/2026		A		24,000		(3)	(3)	Class A Common Stock	24,000	$0	24,000	D
Stock Option (Right to Buy)	$8.62	03/13/2026		A		27,000		(3)	03/13/2036	Class A Common Stock	27,000	$0	27,000	D
Restricted Stock Units	(1)	03/13/2026		M			3,455	(4)	(4)	Class A Common Stock	3,455	$0	0	D
Restricted Stock Units	(1)	03/13/2026		M			3,500	(2)	(2)	Class A Common Stock	3,500	$0	10,500	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.

2. The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2025, in each case subject to the Reporting Person continuing in service through the applicable vesting date.

3. The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2026, in each case subject to the Reporting Person continuing in service through the applicable vesting date.

4. The original grant of 13,823 RSUs vest in four approximately equal annual installments beginning on March 14, 2023.

Remarks:

	/s/ Anthony D'Adamio, Attorney-in-Fact	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Bioventus (BVS) report for Katrina J. Church?

Bioventus reported that Katrina J. Church received new grants of restricted stock units and stock options and exercised previously granted RSUs. Some resulting shares were withheld to satisfy tax obligations, and her direct Class A common stock holdings increased, as detailed in the Form 4.

How many RSUs were granted to Katrina J. Church at Bioventus (BVS)?

Katrina J. Church was granted 24,000 restricted stock units. Each RSU represents a contingent right to receive one share of Class A common stock, vesting in four equal annual installments beginning March 15, 2026, provided she continues in service through each vesting date.

What stock options did Katrina J. Church receive from Bioventus (BVS)?

She received 27,000 stock options with an exercise price of $8.62 per share. These options vest in four equal annual installments starting March 15, 2026, conditioned on her continued service, and are exercisable into Class A common stock through their stated expiration date.

Did Katrina J. Church sell any Bioventus (BVS) shares in the market?

The filing shows no open-market sales. Instead, 3,022 shares of Class A common stock were disposed of under code F, meaning they were withheld by the issuer to cover tax liabilities related to equity award exercises, not sold on the open market.

How many Bioventus (BVS) RSUs did Katrina J. Church exercise?

She exercised a total of 6,955 restricted stock units, converting them into Class A common shares. These exercises reflect previously granted awards, with a portion of the resulting shares withheld to satisfy taxes, as is typical for equity-based compensation events.

What is Katrina J. Church’s Bioventus (BVS) shareholding after these transactions?

After the reported transactions, Katrina J. Church directly holds 61,732 shares of Bioventus Class A common stock. This figure reflects the RSU exercises and tax-withholding share dispositions reported on March 13, 2026, and represents her direct ownership position following the Form 4 events.